Response to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: the Spanish multicenter DIHANA study
JR Valdizán-Usón,1 A Cánovas-Martínez,2 MT De Lucas-Taracena,3 F Díaz-Atienza,4 LS Eddy-Ives,5 A Fernández-Jaén,6 M Fernández-Pérez,7 M García-Giral,8...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8b681678684c4f41861cbfafc5e7256b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:8b681678684c4f41861cbfafc5e7256b |
---|---|
record_format |
dspace |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Valdizán-Usón JR Cánovas-Martínez A De Lucas-Taracena M Díaz-Atienza F Eddy-Ives LS Fernández-Jaén A Fernández-Pérez M García-Giral M García-Magán P Garraus-Oneca M Idiazábal-Alecha MA López-Benito M Lorenzo-Sanz G Martínez-Antón J Martínez-Granero MA Montañés-Rada F Mulas-Delgado F Ochando-Perales G Ortega-García E Pelaz-Antolín A Ramos-Quiroga JA Ruiz-Sanz FC Vaquerizo-Madrid J Yusta-Izquierdo A Response to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: the Spanish multicenter DIHANA study |
description |
JR Valdizán-Usón,1 A Cánovas-Martínez,2 MT De Lucas-Taracena,3 F Díaz-Atienza,4 LS Eddy-Ives,5 A Fernández-Jaén,6 M Fernández-Pérez,7 M García-Giral,8 P García-Magán,9 M Garraus-Oneca,10 MA Idiazábal-Alecha,11 M López-Benito,12 G Lorenzo-Sanz,13 J Martínez-Antón,14 MA Martínez-Granero,15 F Montañés-Rada,16 F Mulas-Delgado,17 G Ochando-Perales,18 E Ortega-García,19 A Pelaz-Antolín,20 JA Ramos-Quiroga,21 FC Ruiz-Sanz,22 J Vaquerizo-Madrid,23 A Yusta-Izquierdo241Unidad Trastornos Neurofuncionales, Clínica Montpellier, Zaragoza, 2Hospital Dr Peset, Valencia, 3Hospital 12 de Octubre, Madrid, 4Hospital Virgen de las Nieves, Granada, 5Centre Mèdic Sant Ramon, Santa Coloma de Gramenet, Barcelona, 6Hospital Universitario Quirón, Madrid, 7Centro de Salud La Felguera, Langreo, Asturias, 8Hospital Clínic, Barcelona, 9Unidad Salud Mental, Talavera de la Reina, 10Clínica Universitaria de Navarra, Pamplona, 11Hospital Ntra. Sra. del Pilar, Barcelona, 12Centro Salud Contrueces, Gijón, 13Hospital Ramón y Cajal, Madrid, 14Complejo Hospitalario Carlos Haya, Málaga, 15Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, 16Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, 17Hospital Universitario La Fe, Valencia, 18Hospital Universitario La Fe, Valencia, 19Complejo Asistencial Universitario de León, 20Centro Salud Mental, Alcalá de Henares, 21Hospital Universitari Vall d'Hebron. CIBERSAM. Department of Psychiatry and Legal Medicine. Universitat Autònoma de Barcelona, 22Hospital General Rio Carrión, Palencia, 23Hospital Materno-Infantil, Badajoz, 24Hospital Universitario, Guadalajara, SpainBackground: The purpose of this multicenter Spanish study was to evaluate the response to immediate-release methylphenidate by children and adults diagnosed with attention-deficit/hyperactivity disorder (ADHD), as well as to obtain information on current therapy patterns and safety characteristics.Methods: This multicenter, observational, retrospective, noninterventional study included 730 patients aged 4–65 years with a diagnosis of ADHD. Information was obtained based on a review of medical records for the years 2002–2006 in sequential order.Results: The ADHD predominantly inattentive subtype affected 29.7% of patients, ADHD predominantly hyperactive-impulsive was found in 5.2%, and the combined subtype in 65.1%. Overall, a significant lower Clinical Global Impression (CGI) score and mean number of DSM-IV TR (Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision) symptoms by subtype were found after one year of treatment with immediate-release methylphenidate; CGI decreased from 4.51 to 1.69, symptoms of inattention from 7.90 to 4.34, symptoms of hyperactivity from 6.73 to 3.39, and combined subtype symptoms from 14.62 to 7.7. Satisfaction with immediate-release methylphenidate after one year was evaluated as “very satisfied” or “satisfied” by 86.90% of the sample; 25.75% of all patients reported at least one adverse effect. At the end of the study, 41.47% of all the patients treated with immediate-release methylphenidate were still receiving it, with a mean time of 3.80 years on therapy.Conclusion: Good efficacy and safety results were found for immediate-release methylphenidate in patients with ADHD.Keywords: attention deficit hyperactivity disorder, ADHD, pharmacologic treatment, methylphenidate, satisfaction |
format |
article |
author |
Valdizán-Usón JR Cánovas-Martínez A De Lucas-Taracena M Díaz-Atienza F Eddy-Ives LS Fernández-Jaén A Fernández-Pérez M García-Giral M García-Magán P Garraus-Oneca M Idiazábal-Alecha MA López-Benito M Lorenzo-Sanz G Martínez-Antón J Martínez-Granero MA Montañés-Rada F Mulas-Delgado F Ochando-Perales G Ortega-García E Pelaz-Antolín A Ramos-Quiroga JA Ruiz-Sanz FC Vaquerizo-Madrid J Yusta-Izquierdo A |
author_facet |
Valdizán-Usón JR Cánovas-Martínez A De Lucas-Taracena M Díaz-Atienza F Eddy-Ives LS Fernández-Jaén A Fernández-Pérez M García-Giral M García-Magán P Garraus-Oneca M Idiazábal-Alecha MA López-Benito M Lorenzo-Sanz G Martínez-Antón J Martínez-Granero MA Montañés-Rada F Mulas-Delgado F Ochando-Perales G Ortega-García E Pelaz-Antolín A Ramos-Quiroga JA Ruiz-Sanz FC Vaquerizo-Madrid J Yusta-Izquierdo A |
author_sort |
Valdizán-Usón JR |
title |
Response to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: the Spanish multicenter DIHANA study |
title_short |
Response to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: the Spanish multicenter DIHANA study |
title_full |
Response to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: the Spanish multicenter DIHANA study |
title_fullStr |
Response to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: the Spanish multicenter DIHANA study |
title_full_unstemmed |
Response to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: the Spanish multicenter DIHANA study |
title_sort |
response to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: the spanish multicenter dihana study |
publisher |
Dove Medical Press |
publishDate |
2013 |
url |
https://doaj.org/article/8b681678684c4f41861cbfafc5e7256b |
work_keys_str_mv |
AT valdizampaacutenusampoacutenjr responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy AT campaacutenovasmartampiacuteneza responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy AT delucastaracenam responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy AT dampiacuteazatienzaf responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy AT eddyivesls responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy AT fernampaacutendezjaampeacutena responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy AT fernampaacutendezpampeacuterezm responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy AT garcampiacuteagiralm responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy AT garcampiacuteamagampaacutenp responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy AT garrausonecam responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy AT idiazampaacutebalalechama responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy AT lampoacutepezbenitom responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy AT lorenzosanzg responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy AT martampiacutenezantampoacutenj responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy AT martampiacutenezgraneroma responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy AT montaampntildeampeacutesradaf responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy AT mulasdelgadof responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy AT ochandoperalesg responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy AT ortegagarcampiacuteae responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy AT pelazantolampiacutena responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy AT ramosquirogaja responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy AT ruizsanzfc responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy AT vaquerizomadridj responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy AT yustaizquierdoa responsetomethylphenidatebyadultandpediatricpatientswithattentiondeficithyperactivitydisorderthespanishmulticenterdihanastudy |
_version_ |
1718401503049285632 |
spelling |
oai:doaj.org-article:8b681678684c4f41861cbfafc5e7256b2021-12-02T04:02:35ZResponse to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: the Spanish multicenter DIHANA study1176-63281178-2021https://doaj.org/article/8b681678684c4f41861cbfafc5e7256b2013-02-01T00:00:00Zhttp://www.dovepress.com/response-to-methylphenidate-by-adult-and-pediatric-patients-with-atten-a12163https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021JR Valdizán-Usón,1 A Cánovas-Martínez,2 MT De Lucas-Taracena,3 F Díaz-Atienza,4 LS Eddy-Ives,5 A Fernández-Jaén,6 M Fernández-Pérez,7 M García-Giral,8 P García-Magán,9 M Garraus-Oneca,10 MA Idiazábal-Alecha,11 M López-Benito,12 G Lorenzo-Sanz,13 J Martínez-Antón,14 MA Martínez-Granero,15 F Montañés-Rada,16 F Mulas-Delgado,17 G Ochando-Perales,18 E Ortega-García,19 A Pelaz-Antolín,20 JA Ramos-Quiroga,21 FC Ruiz-Sanz,22 J Vaquerizo-Madrid,23 A Yusta-Izquierdo241Unidad Trastornos Neurofuncionales, Clínica Montpellier, Zaragoza, 2Hospital Dr Peset, Valencia, 3Hospital 12 de Octubre, Madrid, 4Hospital Virgen de las Nieves, Granada, 5Centre Mèdic Sant Ramon, Santa Coloma de Gramenet, Barcelona, 6Hospital Universitario Quirón, Madrid, 7Centro de Salud La Felguera, Langreo, Asturias, 8Hospital Clínic, Barcelona, 9Unidad Salud Mental, Talavera de la Reina, 10Clínica Universitaria de Navarra, Pamplona, 11Hospital Ntra. Sra. del Pilar, Barcelona, 12Centro Salud Contrueces, Gijón, 13Hospital Ramón y Cajal, Madrid, 14Complejo Hospitalario Carlos Haya, Málaga, 15Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, 16Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, 17Hospital Universitario La Fe, Valencia, 18Hospital Universitario La Fe, Valencia, 19Complejo Asistencial Universitario de León, 20Centro Salud Mental, Alcalá de Henares, 21Hospital Universitari Vall d'Hebron. CIBERSAM. Department of Psychiatry and Legal Medicine. Universitat Autònoma de Barcelona, 22Hospital General Rio Carrión, Palencia, 23Hospital Materno-Infantil, Badajoz, 24Hospital Universitario, Guadalajara, SpainBackground: The purpose of this multicenter Spanish study was to evaluate the response to immediate-release methylphenidate by children and adults diagnosed with attention-deficit/hyperactivity disorder (ADHD), as well as to obtain information on current therapy patterns and safety characteristics.Methods: This multicenter, observational, retrospective, noninterventional study included 730 patients aged 4–65 years with a diagnosis of ADHD. Information was obtained based on a review of medical records for the years 2002–2006 in sequential order.Results: The ADHD predominantly inattentive subtype affected 29.7% of patients, ADHD predominantly hyperactive-impulsive was found in 5.2%, and the combined subtype in 65.1%. Overall, a significant lower Clinical Global Impression (CGI) score and mean number of DSM-IV TR (Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision) symptoms by subtype were found after one year of treatment with immediate-release methylphenidate; CGI decreased from 4.51 to 1.69, symptoms of inattention from 7.90 to 4.34, symptoms of hyperactivity from 6.73 to 3.39, and combined subtype symptoms from 14.62 to 7.7. Satisfaction with immediate-release methylphenidate after one year was evaluated as “very satisfied” or “satisfied” by 86.90% of the sample; 25.75% of all patients reported at least one adverse effect. At the end of the study, 41.47% of all the patients treated with immediate-release methylphenidate were still receiving it, with a mean time of 3.80 years on therapy.Conclusion: Good efficacy and safety results were found for immediate-release methylphenidate in patients with ADHD.Keywords: attention deficit hyperactivity disorder, ADHD, pharmacologic treatment, methylphenidate, satisfactionValdizán-Usón JRCánovas-Martínez ADe Lucas-Taracena MDíaz-Atienza FEddy-Ives LSFernández-Jaén AFernández-Pérez MGarcía-Giral MGarcía-Magán PGarraus-Oneca MIdiazábal-Alecha MALópez-Benito MLorenzo-Sanz GMartínez-Antón JMartínez-Granero MAMontañés-Rada FMulas-Delgado FOchando-Perales GOrtega-García EPelaz-Antolín ARamos-Quiroga JARuiz-Sanz FCVaquerizo-Madrid JYusta-Izquierdo ADove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2013, Iss default, Pp 211-218 (2013) |